Alpha-1 Antitrypsin Deficiency
📧 Sign up to get email alerts when something new happens for Alpha-1 Antitrypsin Deficiency.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2025-03-27EMA Authorised: Respreeza (human alpha1-proteinase inhibitor) — CSL Behring GmbH
The EMA authorised Respreeza (human alpha1-proteinase inhibitor) for alpha-1 antitrypsin deficiency–related lung disease.